Home / Peptides / Sermorelin

Sermorelin Dosage: What the Evidence Says (2026)

No marketed product

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

Also called: GRF 1-29, Geref

Regulatory status (US)

There is no FDA-approved sermorelin on the market. The brand Geref was approved in 1997, discontinued in 2008 and withdrawn in 2009; in 2013 the FDA determined it was not withdrawn for safety or effectiveness reasons. Compounded sermorelin does not inherit that old approval.

What it is

A fragment of growth-hormone-releasing hormone that makes the pituitary release growth hormone.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for Sermorelin. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.

Sermorelin reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Safety

Questions

Is Sermorelin FDA-approved?
There is no FDA-approved sermorelin on the market. The brand Geref was approved in 1997, discontinued in 2008 and withdrawn in 2009; in 2013 the FDA determined it was not withdrawn for safety or effectiveness reasons. Compounded sermorelin does not inherit that old approval.
What dose of Sermorelin has been studied?
There is no established human dose. Geref was approved for children with growth hormone deficiency. There is no FDA-reviewed adult dose for any use.
How many units is my Sermorelin dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

BPC-157

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

KLOW and GLOW blends

Seller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.

Sources

  1. Federal Register 2013: Determination that Geref (sermorelin) was not withdrawn for safety or effectiveness
  2. FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
  3. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.